Fig. 1
From: A novel biomarker for identifying HER2-low breast cancer using synthetic MRI
Flowchart illustrating the patient selection methodology utilized in the current study.
Fig. 1 | Scientific Reports
From: A novel biomarker for identifying HER2-low breast cancer using synthetic MRI
Flowchart illustrating the patient selection methodology utilized in the current study.
